Cargando…
Addressing the most neglected diseases through an open research model: The discovery of fenarimols as novel drug candidates for eumycetoma
Eumycetoma is a chronic infectious disease characterized by a large subcutaneous mass, often caused by the fungus Madurella mycetomatis. A combination of surgery and prolonged medication is needed to treat this infection with a success rate of only 30%. There is, therefore, an urgent need to find mo...
Autores principales: | Lim, Wilson, Melse, Youri, Konings, Mickey, Phat Duong, Hung, Eadie, Kimberly, Laleu, Benoît, Perry, Benjamin, Todd, Matthew H., Ioset, Jean-Robert, van de Sande, Wendy W. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940239/ https://www.ncbi.nlm.nih.gov/pubmed/29698504 http://dx.doi.org/10.1371/journal.pntd.0006437 |
Ejemplares similares
-
Screening the pandemic response box identified benzimidazole carbamates, Olorofim and ravuconazole as promising drug candidates for the treatment of eumycetoma
por: Lim, Wilson, et al.
Publicado: (2022) -
Madurella mycetomatis, the main causative agent of eumycetoma, is highly susceptible to olorofim
por: Lim, Wilson, et al.
Publicado: (2020) -
Madurella mycetomatis grains within a eumycetoma lesion are clonal
por: Nyuykonge, Bertrand, et al.
Publicado: (2022) -
The synthetic synergistic cinnamon oil CIN-102 is active against Madurella mycetomatis, the most common causative agent of mycetoma
por: Konings, Mickey, et al.
Publicado: (2021) -
Targeted review of maximum residue levels (MRLs) for fenarimol
por: Bellisai, Giulia, et al.
Publicado: (2023)